SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of $4….
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares Read More »